IPSC Past Earnings image   This IPSC past earnings page last updated 11/11/2022
IPSC Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/10/2022-0.530
Q2 20228/11/2022-0.540
Q1 20225/16/2022-0.660
Q4 20213/17/2022-0.240
Q3 202111/10/2021-0.480
Q2 20218/12/2021-1.930
IPSC Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/10/20220.00B
Q2 20228/11/20220.00B
Q1 20225/16/20220.00B
Q4 20213/17/2022NA
Q3 202111/10/2021NA
Q2 20218/12/2021NA
Quotes delayed 20 minutes

Email EnvelopeFree IPSC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Century Therapeutics (IPSC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

IQV Past Earnings
IRIX Past Earnings
IRMD Past Earnings
IRTC Past Earnings
IRWD Past Earnings
ISEE Past Earnings
ISPC Past Earnings
ISRG Past Earnings
ITCI Past Earnings
ITGR Past Earnings

IPSC Past Earnings Q&A

What was the best and worst IPSC past earnings results?
For Century Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest IPSC past earnings result in our data set was -0.240/share posted in Q4 2021, while the lowest was in Q2 2021 when IPSC posted -1.930/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when IPSC reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q4 2021 at NA of revenue.

  Suggested answer: There are 6 IPSC past earnings results in our data set.

On this page we presented the IPSC past earnings date information for Century Therapeutics. Reviewing that IPSC Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when IPSC posted gaap of -0.240/share. Meanwhile the lowest IPSC past earnings result was in Q2 2021, when IPSC posted gaap of -1.930/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when IPSC reported 0.00B in revenue, while the smallest revenue quarter was Q4 2021 when IPSC reported NA in revenue.

Any self directed investor doing their due diligence on IPSC or any other given stock can benefit from researching all of the Century Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Century Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IPSC. Thanks for visiting, and the next time you need to research IPSC past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: XYF shares outstanding history, CTCT Options Chain, RMD DMA.

 

IPSC Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.